Dogwood Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.6K Buy
178
+139
+356% +$7.55K ﹤0.01% 442
2026
Q1
$2.45K Sell
39
-4
-9% -$320 ﹤0.01% 604
2025
Q4
$4.1K Sell
43
-2
-4% -$196 ﹤0.01% 457
2025
Q3
$4.39K Sell
45
-23
-34% -$2.38K ﹤0.01% 420
2025
Q2
$6.96K Buy
68
+59
+656% +$5.97K ﹤0.01% 351
2025
Q1
$908 Buy
+9
New +$906 ﹤0.01% 435
2024
Q3
– Hold
0
– – – 226
2024
Q2
– Hold
0
– – – 273
2024
Q1
– Hold
0
– – – 273
2023
Q4
– Hold
0
– – – 257

Other funds holding BSX

Dogwood Wealth Management's BSX Position: Q2 2026 in Review

Dogwood Wealth Management increased its Boston Scientific (BSX) stake by 356% in Q2 2026, buying an estimated $7.55K and bringing the position to 178 shares worth $7.6K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

Dogwood Wealth Management first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Dogwood Wealth Management held 178 shares of Boston Scientific worth $7.6K as of Q2 2026.
  • Dogwood Wealth Management bought 139 Boston Scientific shares in Q2 2026, an estimated $7.55K.
  • Boston Scientific made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #442 holding.
  • Dogwood Wealth Management first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.